Explore 3 Stock Ideas & Industry Insights Download Free Report

blue-chip

Anglo American Profit Plunge and Dividend Cut Signal Strategic Strain - AAL

Sep 01, 2025 | Team Kalkine
Anglo American Profit Plunge and Dividend Cut Signal Strategic Strain - AAL
Image source: shutterstock

  • AAL:LSE
  • Investment Type
    Large-cap
  • Risk Level
  • Action
  • Rec. Price (GBX)

Anglo American PLC

Anglo American PLC (LSE: AAL) is a mining company which is listed under the FTSE 100 index with a portfolio of undeveloped resources, mining, and processing operations. The company’s operations are segmented into Platinum Group Metals, Iron Ore, Manganese, Copper, DeBeers, and Crop Nutrients. This Report covers the Investment Highlights, Conclusion, and Recommendation on the stock.

Key Recommendation Rationale – Sell at GBX 2,279.00

  • Resistance near Current levels: AAL’s stock price breached the Resistance (R2) which was stated in the previous report on 09 April 2025 therefore, there could be a possibility that the stock might consolidate or decline from the current levels, considering overstretched valuation. Considering the market conditions and the price action, it is prudent to exit from the stock.
  • Earnings Contraction and Profitability Decline: The company reported a substantial decline in its financial performance. Underlying EBITDA from continuing operations fell by 20% to USD 3.0 billion, down from USD 3.7 billion in the same period last year. Basic underlying earnings per share from total operations experienced a severe 86% decrease to USD 0.15. This contraction is attributed to challenging market conditions, particularly in diamonds, and lower production volumes in key divisions like copper, indicating underlying operational and market headwinds that are pressuring profitability.
  • Deteriorating Debt Position and Elevated Leverage: Anglo American's net debt increased to USD 10.8 billion, prior to receiving proceeds from planned asset sales. This has resulted in a net debt to EBITDA ratio rising to 1.8x, up from 1.3x at the end of 2024. The ratio is described as "temporarily elevated," but it reflects a period where debt levels are growing while earnings are shrinking. The company's reliance on the successful completion and receipt of proceeds from its portfolio simplification strategy to deleverage introduces a element of execution risk to its balance sheet health.

Valuation Methodology: Price/ Earnings Approach

 Share Price Chart  

One-Year Technical Price Chart (as of September 01, 2025). Source: REFINITIV, Analysis: Kalkine Group

Conclusion

The company is experiencing a period of financial strain, characterized by a contraction in earnings and a decline in profitability. This is evidenced by a reduction in underlying EBITDA and a pronounced decrease in earnings per share, primarily driven by adverse market conditions and lower operational output. Concurrently, the company's financial leverage has increased, as reflected in a higher net debt to EBITDA ratio. This elevation in leverage coincides with a reduction in earnings, indicating a narrowing capacity to service its debt obligations. The organization's strategy to address its balance sheet is contingent upon the execution of its asset disposal plans, introducing a degree of uncertainty regarding the timeline and successful completion of these financial deleveraging actions.

For conducting the valuation, the following peers have been considered: South32 Ltd (LSE: S32), BHP Group Ltd (LSE: BHP), etc

Given its current trading levels, the recent strategic investments and partnerships, relative valuation, and associated risks, it is prudent to exit the stock at the current levels.

Hence, a ‘Sell’ recommendation is given on the stock at the Current Market Price of GBX 2,279.00 as of 01 September 2025 at 09:42 AM GMT +1.

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels is 01 September 2025. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Target Price refers to a price level which the stock is expected to reach as per the relative valuation method and/or technical analysis taking into consideration both short-term and long-term scenario.

Note 5: ‘Kalkine reports are prepared based on the stock prices captured either from the London Stock Exchange (LSE) and or REFINITIV. Typically, both sources (LSE and or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.’


Disclaimer-

This report has been issued by Kalkine Limited (Company number 07903332), a private limited company, incorporated in England and Wales ("Kalkine”). Kalkine.co.uk and associated pages are published by Kalkine. Kalkine is authorised and regulated by the Financial Conduct Authority under reference number 579414.

The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites.  All information represents our views at the date of publication and may change without notice. The information in this report does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products. Our reports contain non personalized recommendations to invest in securities and other financial products.

Kalkine does not offer financial advice based upon your personal financial situation or goals, and we shall not be held liable for any investment or trading losses you may incur by using the opinions expressed in our reports, publications, market updates, news alerts and corporate profiles. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. Kalkine’s non-personalised advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested.

Please also read our Terms & Conditions for further information. Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this report or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Kalkine Media Limited, an affiliate of Kalkine, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website including entities covered in this report.

Past performance is not a reliable indicator of future performance.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions